| 000 | 00989 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517141052.0 | ||
| 264 | 0 | _c20180726 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1531-8257 | ||
| 024 | 7 |
_a10.1002/mds.26935 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOlanow, C Warren | |
| 245 | 0 | 0 |
_aTargeting α-Synuclein as a therapy for Parkinson's disease: The battle begins. _h[electronic resource] |
| 260 |
_bMovement disorders : official journal of the Movement Disorder Society _c02 2017 |
||
| 300 |
_a203-207 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeurons |
| 650 | 0 | 4 | _aParkinson Disease |
| 650 | 0 | 4 | _aSubstantia Nigra |
| 650 | 0 | 4 | _aalpha-Synuclein |
| 700 | 1 | _aKordower, Jeffrey H | |
| 773 | 0 |
_tMovement disorders : official journal of the Movement Disorder Society _gvol. 32 _gno. 2 _gp. 203-207 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/mds.26935 _zAvailable from publisher's website |
| 999 |
_c26897372 _d26897372 |
||